GSK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-term ambition to jointly deliver new medicine to patients in the next 5-10 years.
An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
A combination of nanotechnology and a unique twisting property of light could lead to new methods for ensuring the purity and safety of pharmaceuticals.
Research provides insight into novel approach which could be used in pharmaceutical drug synthesis.
A new study reveals how drug reimbursement policy in Poland is leaving gaping loopholes for pharmaceutical firms to exploit, raising questions about other, post-communist, EU member states.
© 2025 University of Cambridge